{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-039153","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.130867+00:00","generated_at":"2026-06-17T09:19:56.377961+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Eyenovia reports FY2022 net loss $28.0M; Mydcombi PDUFA date May 8, 2023","bullets":["Net loss $28.0M ($0.83/share) for FY2022 vs $12.8M loss in FY2021; Q4 loss $6.1M.","Cash and equivalents $22.9M at Dec 31, 2022, down from $27.3M at Dec 31, 2021.","FDA accepted Mydcombi NDA; PDUFA action target date May 8, 2023.","Positive Phase 3 results for Microline (presbyopia); FDA feedback outlines clear path forward.","Co-development agreement with Formosa Pharmaceuticals to combine Optejet with APNT nanoparticle platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-039153","json":"https://secwatch.observer/filing/0001104659-23-039153.json","markdown":"https://secwatch.observer/filing/0001104659-23-039153.md","text":"https://secwatch.observer/filing/0001104659-23-039153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465923039153/0001104659-23-039153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465923039153/tm2311016d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:19:56.377961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"403b877610241424e158939a235299b4faca2854","claim":"HYPERION DEFI, INC. reported fourth quarter ended December 31, 2022 results: net income net loss was approximately $[6.1] million, or $[0.17] per share, EPS $[0.17] per share.","evidence_excerpt":"For the fourth quarter of 2022, net loss was approximately $[6.1] million, or $[0.17] per share compared to a net income of approximately $3.0 million, or $0.11 per share, for the fourth quarter of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465923039153/0001104659-23-039153-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Net income","value":"net loss was approximately $[6.1] million, or $[0.17] per share"},{"label":"EPS","value":"$[0.17] per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e5e608ab87f5ca5d056e0654eda8bd356a439895","claim":"HYPERION DEFI, INC. reported fiscal year ended December 31, 2022 results: net income net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o, EPS $[0.83] per share.","evidence_excerpt":"For the full-year 2022, net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares outstanding, and this compares to a net loss of approximately $[12.8] million, or $[0.49] per share, for the full year 2021 on approximately 26.3 million weighted average shares outstanding.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465923039153/0001104659-23-039153-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended December 31, 2022"},{"label":"Net income","value":"net loss was approximately $[28.0] million, or $[0.83] per share on approximately 33.6 million weighted average shares o"},{"label":"EPS","value":"$[0.83] per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}